Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Treasury Shares (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Treasury Shares for 9 consecutive years, with $1.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Treasury Shares rose 118.35% year-over-year to $1.2 million, compared with a TTM value of $1.2 million through Sep 2025, up 118.35%, and an annual FY2024 reading of $584309.0, up 125.7% over the prior year.
  • Treasury Shares was $1.2 million for Q3 2025 at Rockwell Medical, up from $891.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.2 million in Q3 2025 and bottomed at $891.0 in Q1 2022.
  • Average Treasury Shares over 5 years is $185385.1, with a median of $7118.0 recorded in 2021.
  • The sharpest move saw Treasury Shares surged 59867.34% in 2024, then tumbled 99.83% in 2025.
  • Year by year, Treasury Shares stood at $7118.0 in 2021, then tumbled by 87.48% to $891.0 in 2022, then surged by 28955.56% to $258885.0 in 2023, then soared by 125.7% to $584309.0 in 2024, then soared by 99.66% to $1.2 million in 2025.
  • Business Quant data shows Treasury Shares for RMTI at $1.2 million in Q3 2025, $891.0 in Q2 2025, and $383326.0 in Q1 2025.